Stay updated on Pembrolizumab for Bladder Cancer Surgery Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Bladder Cancer Surgery Clinical Trial page.

Latest updates to the Pembrolizumab for Bladder Cancer Surgery Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing the previous Revision: v3.6.4.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page now shows a new system revision label (v3.6.4), replacing the previous revision (v3.6.3), indicating a software update to the site’s interface without changing study information.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page revision tag was updated from v3.6.2 to v3.6.3, indicating a minor version update to the page metadata.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page now shows Revision: v3.6.2, replacing Revision: v3.6.0. This indicates a system update deployed to the page for maintenance or bug fixes.SummaryDifference0.1%

- Check70 days agoChange DetectedAdded a recruitment status note stating the study is no longer looking for participants. New help/navigation items were introduced, including How to Read a Study Record, Common Questions, and How to Join a Study.SummaryDifference0.5%

- Check77 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, signaling a new revision of the page content. This appears to be maintenance rather than a substantive change to the study information.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Bladder Cancer Surgery Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Bladder Cancer Surgery Clinical Trial page.